Michael McBride, DO
Dermatology · Phoenix, AZNPI 1508325697
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,077 of the $11,532 with a category attached, or 70.0%. 32 manufacturers reported payments, led by Sanofi at 34.4% of the total. 2025 is the largest year on record at $7,497, 4.7 times the $1,611 reported in 2023.
Across 299 payments — averaging $38.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- AbbVie$1K
- UCB, Inc.$920
- Dermavant Sciences, Inc.$851
- LEO Pharma Inc.$623
- E.r. Squibb & Sons, L.L.C.$509
- plus $3K from 26 others
What the payments were for
- Speaking & faculty fees$3,45530%
- Food & beverage$8,07770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 15 | $3,966 |
| AbbVie | 54 | $1,232 |
| UCB, Inc. | 21 | $920 |
| Dermavant Sciences, Inc. | 33 | $851 |
| LEO Pharma Inc. | 24 | $623 |
| E.r. Squibb & Sons, L.L.C. | 16 | $509 |
| Regeneron Healthcare Solutions, Inc. | 11 | $451 |
| Galderma Laboratories, L.p. | 13 | $375 |
| Novartis | 11 | $368 |
| Johnson & Johnson | 30 | $354 |
| Incyte Corporation | 5 | $349 |
| Lilly USA, LLC | 12 | $226 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $225 |
| Pfizer | 9 | $205 |
| Janssen Scientific Affairs, LLC | 4 | $159 |
| Regeneron | 1 | $108 |
| Organon | 6 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $85 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
| Sun Pharmaceutical Industries Inc. | 3 | $64 |
| Botanix SB Inc | 2 | $48 |
| Amgen | 2 | $41 |
| Hill Dermaceuticals, Inc. | 1 | $35 |
| Verrica Pharmaceuticals Inc. | 2 | $31 |
| Boehringer Ingelheim | 1 | $30 |
| Fresenius Kabi USA, LLC | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Surgenex LLC | 1 | $18 |
| Sandoz | 1 | $18 |
| Almirall LLC | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $12 |
| Biofrontera Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,532 in reported general payments places this provider in the 80th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 45 | $3,014 |
| Ketoconazole | 88 | $1,592 |
| Clobetasol Propionate | 38 | $1,464 |
| Triamcinolone Acetonide | 72 | $884 |
| Betamethasone Dipropionate | 17 | $769 |
| Clindamycin Phosphate | 24 | $623 |
| Doxycycline Hyclate | 23 | $568 |
| ValacyclovirValacyclovir Hcl | 12 | $228 |
| Nystatin | 11 | $211 |
| Hydrocortisone | 46 | $194 |
| Spironolactone | 12 | $179 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Phoenix
- Lindsay AckermanPhoenix$1.6M
- Nathalie ZeitouniPhoenix$584K
- Carsten HamannPhoenix$364K
- Michael CrandallPhoenix$153K
- Sadra JazayeriPhoenix$115K
- Cynthia PricePhoenix$76K
- William KoPhoenix$66K
- Dathan HamannPhoenix$56K
- Peter SigalPhoenix$30K
- Xuan NguyenPhoenix$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.